From: Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon
 | CIC, n (%) | CHW, n (%) | Total, n (%) | P-value* |
---|---|---|---|---|
Variable | ||||
Participants recruited | 1356 (69.9%) | 584 (30.1%) | 1940 (100%) | Â |
Age (years), mean ± SD | 39.4 (±5.9) | 41.9 (±5.6) | 40.2 (±5.9) | <  0.001 |
Marital status |  |  |  | <  0.001 |
 Single | 121 (8.9%) | 25 (4.3%) | 146 (7.5%) |  |
 Married/In a relationship | 1155 (85.2%) | 494 (84.6%) | 1649 (85%) |  |
 Divorced/widowed | 78 (5.8%) | 64 (11.0%) | 142 (7.3%) |  |
Education |  |  |  | <  0.001 |
 Unschooled | 5 (0.4%) | 9 (1.5%) | 14 (0.7%) |  |
 Primary education | 275 (20.3%) | 274 (46.9%) | 549 (28.3%) |  |
 Secondary education | 759 (56.0%) | 274 (46.9%) | 1033 (53.3%) |  |
 Tertiary education | 315 (23.2%) | 24 (4.1%) | 339 (17.5%) |  |
Employment status |  |  |  | <  0.001 |
 Employed | 480 (35.4%) | 62 (10.6%) | 542 (27.9%) |  |
 Self-employed | 412 (30.4%) | 121 (20.7%) | 533 (27.5%) |  |
 Farmer | 130 (10.0%) | 249 (42.6%) | 379 (19.5%) |  |
 Housewife | 274 (20.2%) | 147 (25.2%) | 421 (21.7%) |  |
 Student | 50 (3.7%) | 4 (0.7%) | 54 (2.8%) |  |
 Unemployed | 8 (0.6%) | 0 | 8 (0.4%) |  |
Age at menarche (years), mean ± SD | 14.6 (1.8) | 14.9 (1.7) | 14.7 (1.8) | <  0.001 |
Age at first intercourse, mean ± SD | 18.0 (2.9) | 17.48 (2.4) | 17.9 (2.8) | <  0.001 |
Number of sexual partners, median (IQR) | 3 (2–5) | 3 (2–4) | 3 (2–5) |  |
Age at first delivery (years), mean ± SD | 21.3 (5.8) | 19.8 (4.3) | 20.9 (5.4) | <  0.001 |
Parity |  |  |  | <  0.001 |
 Nulliparous | 65 (4.8%) | 13 (2.2%) | 78 (4.0%) |  |
 1–4 | 662 (48.8%) | 166 (28.4%) | 828 (42.9%) |  |
  > 4 | 627 (46.2%) | 404 (69.2%) | 1031 (53.1%) |  |
Tabaco consumption |  |  |  | <  0.001 |
 Yes | 7 (0.5%) | 27 (4.6%) | 34 (1.8%) |  |
 None | 1347 (99.3%) | 555 (95.0%) | 1902 (98.0%) |  |
Contraception |  |  |  | <  0.001 |
 None | 924 (68.1%) | 430 (73.6%) | 1354 (69.8%) |  |
 Condom | 189 (13.9%) | 21 (3.6%) | 210 (10.8%) |  |
 Hormonal pill | 23 (1.7%) | 8 (1.4%) | 31 (1.6%) |  |
 DIU/ implant/ injection | 199 (14.7%) | 117 (20.0%) | 316 (16.3%) |  |
 Other | 16 (1.2%) | 5 (0.9%) | 21 (1.1%) |  |
Previous cervical cancer screening |  |  |  | <  0.001 |
 None | 1025 (75.6%) | 560 (95.9%) | 1585 (81.7%) |  |
 Yes | 329 (24.3%) | 23 (3.9%) | 352 (18.1%) |  |
HIV status (self-reported) | Â | Â | Â | 0.791 |
 Negative | 1327 (97.9%) | 574 (98.3%) | 1901 (98.0%) |  |
 Positive | 27 (2.0%) | 9 (1.5%) | 36 (1.9%) |  |
HPV testing results | Â | Â | Â | 0.287 |
 Negative | 1096 (80.8%) | 484 (82.9%) | 1580 (81.4%) |  |
 Positive | 260 (19.2%) | 100 (17.1%) | 360 (18.6%) |  |
 HPV-16/18/45 | 59 (4.4%) | 24 (4.1%) | 83 (4.3%) |  |
 Other HPV | 215(15.9%) | 86 (14.7%) | 301 (15.5%) |  |
Histology (% of HPV positive women) | Â | Â | Â | 0.437 |
 Normal | 179 (68.8%) | 62 (62%) | 241 (66.9%) |  |
 CIN1 | 44 (16.9%) | 18 (18%) | 62 (17.2%) |  |
 CIN2+ | 28 (10.8%) | 11 (11%) | 39 (10.8%) |  |